title: [Pharmacological and clinical profile of gabapentin enacarbil: a novel drug for the treatment of restless legs syndrome].
authors.affiliation: shuichirou.kakimoto@astellas.com
authors.forename: Shuichiro
authors.initials: S
authors.lastname: Kakimoto
authors.forename: Tohru
authors.initials: T
authors.lastname: Ozawa
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Igarashi
authors.forename: Tomoaki
authors.initials: T
authors.lastname: Tokuno
authors.forename: Seiji
authors.initials: S
authors.lastname: Kaku
authors.forename: Nobuo
authors.initials: N
authors.lastname: Seki
mesh_terms: D000818:Animals; D001682:Biological Availability; D002219:Carbamates / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D011355:Prodrugs / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D012148:Restless Legs Syndrome / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: C493250:1-(((alpha-isobutanoyloxyethoxy)carbonyl)aminomethyl)-1-cyclohexaneacetic acid; D002219:Carbamates; D011355:Prodrugs; D005680:gamma-Aminobutyric Acid